(R)-2-(6-Cyclopropylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole

Catalog No. :
ACIQUO189
CAS No. :
2828438-51-1
Molecular Formula :
C17H16N2O
Molecular Weight :
264.33

IUPAC Name:(R)-2-(6-cyclopropylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole

(R)-2-(6-Cyclopropylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$62.00Login to see priceIn stockInquiry
250mg95%$131.00Login to see priceIn stockInquiry
1g95%$405.00Login to see priceIn stockInquiry
5g95%$1618.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-2-(6-Cyclopropylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole
IUPAC Name(R)-2-(6-cyclopropylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole
MDL No.MFCD34705717
Molecular FormulaC17H16N2O
Molecular Weight264.33
SMILESC1(C2CC2)=NC(C3=N[C@@H](CO3)C4=CC=CC=C4)=CC=C1
InChI KeyGSHXRSCOEPAEKW-INIZCTEOSA-N
SynonymPyridine, 2-cyclopropyl-6-[(4R)-4,5-dihydro-4-phenyl-2-oxazolyl]-
CAS No.2828438-51-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACIQUO189 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAQNU854 route compound structure diagram
    ACAQNU854411235-57-9 In Stock
  4. Then
  5. ACIQUO189 route product structure diagram
    ACIQUO1892828438-51-1 In Stock
Inquiry

2. ACIQUO189 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAQNU854 route compound structure diagram
    ACAQNU854411235-57-9 In Stock
  4. Then
  5. ACIQUO189 route product structure diagram
    ACIQUO1892828438-51-1 In Stock
Inquiry

Comments (0)